[Cancer cell transplantation in zebrafish: From translational research to personalized medicine]

Ludivine Raby1, Pamela Völkel2, Xuefen Le Bourhis1

  • 1Inserm U908, Cell Plasticity & Cancer, 59000 Lille, France; University of Lille, 59000 Lille, France.

Bulletin Du Cancer
|August 31, 2019
PubMed

Insights

Zebrafish (Danio rerio) models enable cancer research by allowing in vivo study of tumor development and drug efficacy. This approach aids personalized medicine by testing patient-derived cells for tailored cancer therapies.

Area of Science:

  • Developmental Biology
  • Cancer Research
  • Pharmacology

Background:

  • Zebrafish (Danio rerio) are increasingly utilized as a model organism in cancer research.
  • Cancer cell transplantation in zebrafish offers a platform for studying tumorigenesis and therapeutic efficacy.
  • This model is valuable for investigating cellular and molecular events in cancer development.

Purpose of the Study:

  • To review the zebrafish transplantation model for cancer research.
  • To highlight its application in studying cancer development.
  • To discuss its utility in drug discovery and personalized medicine.

Main Methods:

  • Utilizing zebrafish as an in vivo model for cancer studies.
  • Employing cancer cell transplantation techniques in zebrafish.
  • Applying xenotransplantation with patient-derived cells for personalized medicine.

Main Results:

  • Zebrafish models facilitate the study of tumorigenesis and molecular events.
  • The model allows for in vivo evaluation of therapeutic molecule efficacy.
  • Xenotransplantation in zebrafish supports the identification of personalized therapeutic strategies.

Conclusions:

  • The zebrafish transplantation model is a powerful tool for cancer research.
  • It aids in understanding cancer development and evaluating drug responses.
  • This model contributes to advancing personalized cancer medicine and drug discovery.

Related Concept Videos

Quantifying the Frequency of Tumor-propagating Cells Using Limiting Dilution Cell Transplantation in Syngeneic Zebrafish08:01

Quantifying the Frequency of Tumor-propagating Cells Using Limiting Dilution Cell Transplantation in Syngeneic Zebrafish

Limiting dilution cell transplantation assays are used to determine the frequency of tumor-propagating cells. This protocol describes a method for generating syngeneic zebrafish that develop fluorescently-labeled leukemia and details how to isolate and transplant these leukemia cells at limiting dilution into the peritoneal cavity of adult...
19.7K
High-resolution Cell Transplantation in Embryonic and Larval Zebrafish06:08

High-resolution Cell Transplantation in Embryonic and Larval Zebrafish

Here we present a protocol to transplant cells with high spatial and temporal resolution in zebrafish embryos and larvae at any stage between at least 1 and 7 days post...
1.6K
Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish09:22

Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish

Here, we describe xenograft zebrafish models using two different injection sites, i.e., perivitelline space and duct of Cuvier, to investigate the invasive behavior and to assess the intravasation and extravasation potential of human breast cancer cells,...
17.4K
Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing06:59

Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing

Preclinical models aim to advance the knowledge of cancer biology and predict treatment efficacy. This paper describes the generation of zebrafish-based patient-derived xenografts (zPDXs) with tumor tissue fragments. The zPDXs were treated with chemotherapy, the therapeutic effect of which was assessed in terms of cell apoptosis of the transplanted tissue.
1.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Subcutaneous Transplantation Assay: A Method to Transplant Melanoma Cells from a Donor to a Recipient Zebrafish Model04:05

Subcutaneous Transplantation Assay: A Method to Transplant Melanoma Cells from a Donor to a Recipient Zebrafish Model

This video describes the method for transplantation of tumor cells from the melanoma-bearing donor zebrafish model to an immunocompromised recipient Casper zebrafish. It helps to visualize tumor engraftment and proliferation in the recipient...
1.3K